Freezes and reductions in National Institutes of Health funding are reverberating beyond universities and research labs to startups in the biotech industry.

The shares of Fabtech Technologies began trading on the BSE SME platform at a significant premium of 90% prior to two months ...

Joshua Oduyemi, the Nigerian-American entrepreneur behind Sheatrust Capital, Multicent, and Abbegen, is redefining venture ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

Last November’s election ushered in a new administration, a new Congress, and a new political agenda. One of the Trump ...

BioMarin Pharmaceutical Inc.’s BMRN share price has dipped by 10.70%, which has investors questioning if this is right time ...

Learn more about whether Halozyme Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Australia’s biggest healthcare companies, from global blood plasma giant CSL and surgical gloves supplier Ansell to sleep ...

Thousands of federal workers are out of a job after reduction-in-force notices were sent across HHS on Tuesday, sparking frustration and fear across the health care industry.

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...